Skip to content

Partners
Engagement
Funding
News
About
Contact

Menu

Partners
Engagement
Funding
News
About
Contact

Menu

Psychiatry Consortium

Partners
Engagement
Funding
News
About
Contact

Close Menu

Third call for proposals

Darren September 15, 2021

19th January 2021

Including details of the scope and review process

Second call for proposals Partner Insights

Recent Posts

Target validation in psychiatry: addressing unmet therapeutic needs
Improving translational research along the psychiatric drug discovery pipeline
Meet Dr Laura Ajram from the Psychiatry Consortium
Driving Advances in Drug Discovery for Mental Health Conditions
Meet the Psychiatry Consortium: Driving advances in drug discovery for mental health conditions

Recent Comments

Archives

December 2022
January 2022
September 2021

Categories

events
past
Uncategorized
workshops

Meta

Log in
Entries feed
Comments feed
WordPress.org

Other Blogs

Meet Dr Laura Ajram from the Psychiatry Consortium

Read More
Improving translational research along the psychiatric drug discovery pipeline

Read More

Other News

Psychiatry Consortium brings Charles River Laboratories and Evotec on board

Read More
A new initiative to revitalise drug discovery in psychiatric disease: the Psychiatry Consortium launches first call for proposals

Read More

Other Case Studies

Delivering the next generation drug discovery pipeline; New approaches to target identification and target validation

Read More
Innovative drug discovery consortium to address unmet therapeutic needs of people living with mental health conditions

Read More

Other Resources

Key resources
Webinar recording

Read More

Other Portfolios

Project 1: Investigating KALRN as a novel target for the treatment of schizophrenia

Read More
Project 2: Investigating NEGR1 as a novel target for the treatment of depression

Read More

Other Webinars

Fourth call for proposals

Read More
Second call for proposals

Read More

Other Events

Delivering the next generation drug discovery pipeline

Read More
Psychopharmacology drug discovery in the 21st century

Read More

Alzheimer's Research UK

Boehringer Ingelheim

Johnson & Johnson

Lundbeck

Medicines Discovery Catapult

MQ: Transforming mental health through research

Sign up to our Newsletter

To keep up to date with the latest information about our funding calls and events

Newsletter

Email *

If you are human, leave this field blank.

If you have a question that you can’t find the answer to

Psychiatry Consortium

Catapult Medicines Discovery

Pages

Partners
Engagement
Contact

Legals

Privacy Policy
Terms & Conditions
Intellectual Property Notices
Cookie Policy

Find Us

Block 35, Alderley Park,

Macclesfield, Cheshire, SK10 4ZF

Psychiatry Consortium